Showing results (211-220 of 301) with videos related to
Sort By:
Pageof 31
Bioorganic & Medicinal Chemistry|January 15, 2014
New melatonin (MT1/MT2) ligands: design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivativesElodie Landagaray, Mohamed Ettaoussi, Véronique Leclerc, et al.Respiratory Care|May 24, 2018
Heliox Adjunct Therapy for Neonates With Congenital Diaphragmatic HerniaAudra C Wise, Mallory A Boutin, Ellen M Knodel, et al.Pharmacology Research & Perspectives|January 2, 2020
Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT1 and MT2 receptorsCéline Legros, Clémence Dupré, Chantal Brasseur, et al.Journal of Natural Products|July 4, 2009
Cytotoxic pentacyclic triterpenoids from Combretum sundaicum and Lantana camara as inhibitors of Bcl-xL/BakBH3 domain peptide interactionMarc Litaudon, Claire Jolly, Catherine Le Callonec, et al.Analytical Biochemistry|February 17, 2015
¹⁹F nuclear magnetic resonance screening of glucokinase activatorsO Assemat, M Antoine, J-M Fourquez, et al.Cellular Signalling|July 24, 2002
Ligand modulation of [35S]GTPgammaS binding at human alpha(2A), alpha(2B) and alpha(2C) adrenoceptorsValérie Audinot, Nelly Fabry, Jean-Paul Nicolas, et al.Acta Pharmacologica Sinica|May 27, 2008
High-throughput screening of novel antagonists on melanin-concentrating hormone receptor-1Jian-hua Yan, Qun-yi Li, Jean A Boutin, et al.Lab on a Chip|September 9, 2015
Polymer-based microfluidic chip for rapid and efficient immunomagnetic capture and release of Listeria monocytogenesL Malic, X Zhang, D Brassard, et al.European Journal of Medicinal Chemistry|January 18, 2006
New ligands at the melatonin binding site MT(3)Marie-Françoise Boussard, Sandrine Truche, Anne Rousseau-Rojas, et al.Bioorganic & Medicinal Chemistry|January 23, 2003
Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligandsSaíd Yous, Sophie Durieux-Poissonnier, Emmanuelle Lipka-Belloli, et al.Pageof 31